United States (US) Contract Cell and Gene Therapy Manufacturing Market (2025-2031) Outlook | Share, Growth, Forecast, Analysis, Value, Industry, Companies, Trends, Size, Revenue

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Contract Cell and Gene Therapy Manufacturing Market - Industry Life Cycle

3.4 United States (US) Contract Cell and Gene Therapy Manufacturing Market - Porter's Five Forces

3.5 United States (US) Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume Share, By Vector, 2021 & 2031F

3.6 United States (US) Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume Share, By Indication, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing demand for personalized medicine and advanced therapies

4.2.2 Growth in RD investments in cell and gene therapy

4.2.3 Favorable regulatory environment supporting innovation in the sector

4.3 Market Restraints

4.3.1 High costs associated with cell and gene therapy manufacturing

4.3.2 Limited skilled workforce in specialized manufacturing techniques

4.3.3 Challenges related to scalability and standardization of manufacturing processes

6.1 United States (US) Contract Cell and Gene Therapy Manufacturing Market, By Vector

6.1.1 Overview and Analysis

6.1.2 United States (US) Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Vector, 2018 - 2027F

6.1.3 United States (US) Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Viral Vector, 2018 - 2027F

6.1.4 United States (US) Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Non-viral Vector, 2018 - 2027F

6.2 United States (US) Contract Cell and Gene Therapy Manufacturing Market, By Indication

6.2.1 Overview and Analysis

6.2.2 United States (US) Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Cancer, 2018 - 2027F

6.2.3 United States (US) Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Neurological Diseases, 2018 - 2027F

6.2.4 United States (US) Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Hepatological Diseases, 2018 - 2027F

6.2.5 United States (US) Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Others, 2018 - 2027F

7.1 United States (US) Contract Cell and Gene Therapy Manufacturing Market Export to Major Countries

7.2 United States (US) Contract Cell and Gene Therapy Manufacturing Market Imports from Major Countries

8.1 Average production cycle time for contract manufacturing

8.2 Number of partnerships and collaborations in the cell and gene therapy manufacturing sector

8.3 Rate of adoption of automation and digital technologies in manufacturing processes

9.1 United States (US) Contract Cell and Gene Therapy Manufacturing Market Opportunity Assessment, By Vector, 2021 & 2031F

9.2 United States (US) Contract Cell and Gene Therapy Manufacturing Market Opportunity Assessment, By Indication, 2021 & 2031F

10.1 United States (US) Contract Cell and Gene Therapy Manufacturing Market Revenue Share, By Companies, 2021

10.2 United States (US) Contract Cell and Gene Therapy Manufacturing Market Competitive Benchmarking, By Operating and Technical Parameters